Abstract
The cellular response to DNA damage is vital for maintaining genomic stability and preventing undue cell death or cancer formation. The DNA damage response (DDR), most robustly mobilized by double-strand breaks (DSBs), rapidly activates an extensive signaling network that affects numerous cellular systems, leading to cell survival or programmed cell death. A major component of the DDR is the widespread modulation of gene expression. We analyzed together six datasets that probed transcriptional responses to ionizing radiation (IR) - our novel experimental data and 5 published datasets - to elucidate the scope of this response and identify its gene targets. According to the mRNA expression profiles we recorded from 5 cancerous and non-cancerous human cell lines after exposure to 5 Gy of IR, most of the responses were cell line-specific. Computational analysis identified significant enrichment for p53 target genes and cell cycle-related pathways among groups of up-regulated and down-regulated genes, respectively. Computational promoter analysis of the six datasets disclosed that a statistically significant number of the induced genes contained p53 binding site signatures. p53-mediated regulation had previously been documented for subsets of these gene groups, making our lists a source of novel potential p53 targets. Real-time qPCR and chromatin immunoprecipitation (ChIP) assays validated the IR-induced p53-dependent induction and p53 binding to the respective promoters of 11 selected genes. Our results demonstrate the power of a combined computational and experimental approach to identify new transcriptional targets in the DNA damage response network.
Original language | English |
---|---|
Pages (from-to) | 336-348 |
Number of pages | 13 |
Journal | Molecular Oncology |
Volume | 5 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2011 |
Externally published | Yes |
Bibliographical note
Funding Information:This study was supported by the European Community’s Seventh Framework Program (research grant HEALTH-F4-2009-223575 for the TRIREME Project) and The Converging Technologies Program of the Israel Science Foundation (to RS and YS), The European Community’s Seventh Framework Program (Grant HEALTH-F4-2007-200767 for the APO-SYS project to RS), and The Israel Cancer Research Fund and the A-T Medical Research Foundation (to YS). YS is a Research Professor of the Israel Cancer Research Fund.
Funding
This study was supported by the European Community’s Seventh Framework Program (research grant HEALTH-F4-2009-223575 for the TRIREME Project) and The Converging Technologies Program of the Israel Science Foundation (to RS and YS), The European Community’s Seventh Framework Program (Grant HEALTH-F4-2007-200767 for the APO-SYS project to RS), and The Israel Cancer Research Fund and the A-T Medical Research Foundation (to YS). YS is a Research Professor of the Israel Cancer Research Fund.
Funders | Funder number |
---|---|
A-T Medical Research Foundation | |
Converging Technologies Program of the Israel Science Foundation | HEALTH-F4-2007-200767 |
European Community’s Seventh Framework Program | HEALTH-F4-2009-223575 |
Israel Cancer Research Fund | |
Seventh Framework Programme | 223575, 200767 |
Keywords
- DNA damage response
- Gene expression
- Ionizing radiation
- Meta-analysis
- P53
- Transcriptional regulation